Losartan vs Telmisartan: Which BP Medicine Is Better for You?

BBoth are ARBs (Angiotensin Receptor Blockers). Telmisartan: Longer half-life (24 hours - truly once daily). Slightly better organ protection evidence. Pricier. Brands: Telma 40 ₹75, Telmikind 40 ₹40. Losartan: Half-life 6-9 hours. Sometimes needs twice daily. Cheaper. Brands: Losar 50 ₹35, Repace 50 ₹50, Cosart 50 ₹45, Tozaar 50 ₹65. Both lower BP similarly. Telmisartan has edge in once-daily compliance and diabetic kidney protection. Losartan has long history, proven cost-effective, lowers uric acid (useful in gout + BP).

Hypertension + Gout: Losartan mildly lowers uric acid (uricosuric effect) - good two-for-one. BP + Kidney protection when you need cheaper ARB: Losartan's LIFE trial showed kidney + stroke protection. Young patient with mild-moderate hypertension, cost-conscious: Losar 50mg ₹35/month is excellent value. Left ventricular hypertrophy (thickened heart wall): Both work; losartan has specific trial data. Kids/adolescents (rare BP): Losartan approved in kids down to 6 years. Dose: 50mg once daily, increase to 100mg if needed. Can be split to 50mg BD for better coverage.

Diabetic with hypertension: Telmisartan has strongest diabetic kidney protection data - reduces albuminuria, delays nephropathy progression. Once-daily compliance: 24-hour coverage means missed morning dose still provides protection. Elderly patient who forgets doses: Telma is forgiving. High cardiovascular risk (history of MI, stroke, peripheral artery disease): ONTARGET trial showed telmisartan equivalent to ramipril for prevention. Obesity, metabolic syndrome: Some evidence for slight metabolic benefit (PPAR-gamma activity). Cost-justified for long-term organ protection in high-risk Indian.

Both very well-tolerated. Both can cause: Dizziness (first days), hyperkalemia (elevated potassium - check blood test yearly), mild kidney function drop in renal artery stenosis (rare), back pain (rare), fatigue. Neither causes persistent dry cough like ramipril/ACE inhibitors (<1% vs 20%). That's why many Indians on ACEi are switched to ARB. Don't mix ACEi + ARB - no added benefit, more side effects. Pregnancy: BOTH Category D - stop immediately if pregnant, switch to methyldopa/labetalol.

Losartan: Start 50mg once daily. If BP not controlled: increase to 100mg once daily OR split 50mg BD. Kids 6-16: 0.7 mg/kg once daily. Max 100mg/day. Telmisartan: Start 40mg once daily (20mg in elderly/mild BP). If not controlled: 80mg once daily. Max 80mg/day. Both: Morning or evening - consistency matters. Can be taken with or without food. Missed dose: take as soon as remembered; if near next dose, skip. Combined tablets: Losar-H, Telma-H (+ HCTZ), Losar-AM, Telma-AM (+ amlodipine).

Monthly cost per month (30 tablets): Losartan 50: ₹30-55. Losartan 100: ₹60-90. Telmisartan 40: ₹40-75. Telmisartan 80: ₹70-130. Monthly difference: ₹30-60 typically. Over years, adds up. If you're budget-sensitive with mild hypertension and no diabetes: Losartan is genuinely fine choice, especially if you have gout/high uric acid. If you're diabetic or high cardiovascular risk: telmisartan's slight kidney/heart edge justifies ₹20/month more. Don't sweat the switch too much - both are excellent BP drugs.